Danaparoid sodium is an antithrombotic agent composed of a mixture of glycosaminoglycans, mainly heparan sulfate, dermatan sulfate, and chondroitin sulfate. It is used as an anticoagulant, particularly in patients with heparin-induced thrombocytopenia (HIT). It is grouped under the following drug class(es): Carbohydrates. Its therapeutic use is listed as anticoagulants. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Suleparoide sodique and Danaparoidum natricum. Its PubChem SID is 483925215.
Danaparoid sodium
| CAS No | 57459-72-0 |
|---|---|
| Molecular Weight | 5,500 Daltons |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Danaparoid sodium is an antithrombotic agent composed of a mixture of glycosaminoglycans, mainly heparan sulfate, dermatan sulfate, and chondroitin sulfate. It is used as an anticoagulant, particularly in patients with heparin-induced thrombocytopenia (HIT).
The listed CAS number is 57459-72-0.
The listed molecular weight is 5,500 Daltons.
The source lists Suleparoide sodique and Danaparoidum natricum.
Its therapeutic use is listed as anticoagulants.
It is listed under Carbohydrates.